本頁面由Tiger Trade Technology Pte. Ltd.提供服務

朴荷生物科技

1.54
-0.0400-2.53%
盤後1.560.0200+1.30%19:51 EST
成交量:3.43萬
成交額:5.22萬
市值:495.96萬
市盈率:-0.04
高:1.59
開:1.52
低:1.40
收:1.58
52周最高:2,074.50
52周最低:1.40
股本:322.05萬
流通股本:278.95萬
量比:0.87
換手率:1.23%
股息:- -
股息率:- -
每股收益(TTM):-41.3800
每股收益(LYR):0.9571
淨資產收益率:-885.84%
總資產收益率:-334.07%
市淨率:1.24
市盈率(LYR):1.61

資料載入中...

2026/03/02

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/23

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/12/05

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/09/25

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/09/19

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/07/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/24

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/20

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/12/20

SEC問詢函

Form CORRESP - Correspondence
2024/12/20

SEC問詢函

Form CORRESP - Correspondence
2024/12/06

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/12/03

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/11/06

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/10/09

SEC問詢函

Form CORRESP - Correspondence
2024/10/09

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/09/18

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/09/18

SEC問詢函

Form CORRESP - Correspondence
2024/08/26

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/08/26

SEC問詢函

Form CORRESP - Correspondence